Multibase India Ltd
Incorporated in 1991, Multibase India Ltd manufactures, trades and sells of polypropylene compound, thermoplastic elastomer, silicon master batch and thermoplastic master
batch[1]
- Market Cap ₹ 217 Cr.
- Current Price ₹ 172
- High / Low ₹ 241 / 151
- Stock P/E 17.6
- Book Value ₹ 76.0
- Dividend Yield 0.00 %
- ROCE 16.7 %
- ROE 12.5 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 4.49% over past five years.
- Company has a low return on equity of 11.3% over last 3 years.
- Debtor days have increased from 59.0 to 74.2 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62 | 70 | 86 | 109 | 110 | 60 | 53 | 62 | 72 | 65 | 71 | 67 | 78 | |
| Sales growth | +13% | +14% | +23% | +26% | +1% | -46% | -11% | +17% | +16% | -10% | +9% | -6% | +14% |
| 51 | 56 | 68 | 80 | 90 | 53 | 47 | 56 | 63 | 56 | 56 | 55 | 64 | |
| Operating Profit | 10 | 14 | 19 | 29 | 20 | 7 | 7 | 7 | 10 | 8 | 15 | 11 | 14 |
| OPM % | 17% | 20% | 22% | 26% | 18% | 11% | 13% | 11% | 13% | 13% | 21% | 17% | 18% |
| 1 | 2 | 2 | 2 | 3 | 4 | 4 | 3 | 5 | 8 | 6 | 4 | 4 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 11 | 15 | 20 | 30 | 22 | 10 | 10 | 9 | 13 | 15 | 20 | 14 | 16 |
| Tax % | 34% | 35% | 35% | 35% | 30% | 24% | 32% | 27% | 26% | 26% | 26% | 25% | |
| 7 | 10 | 13 | 20 | 15 | 8 | 7 | 6 | 10 | 11 | 15 | 10 | 12 | |
| EPS in Rs | 5.72 | 7.83 | 10.52 | 15.49 | 12.17 | 5.97 | 5.32 | 5.02 | 7.76 | 8.84 | 11.61 | 8.26 | 9.77 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 38% | 20% | 26% | 34% | 457% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 4% |
| 3 Years: | -3% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 9% |
| 3 Years: | 2% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -5% |
| 3 Years: | -9% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 9% |
| 3 Years: | 11% |
| Last Year: | 12% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 29 | 38 | 52 | 71 | 87 | 94 | 101 | 105 | 113 | 122 | 66 | 76 | 83 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 6 | 8 | 12 | 32 | 12 | 10 | 12 | 12 | 11 | 10 | 11 | 15 | 23 | |
| Total Liabilities | 47 | 59 | 77 | 116 | 111 | 117 | 126 | 130 | 137 | 144 | 90 | 104 | 119 |
| 5 | 8 | 9 | 10 | 10 | 11 | 10 | 11 | 11 | 12 | 13 | 13 | 13 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 42 | 51 | 68 | 106 | 101 | 106 | 115 | 119 | 126 | 133 | 77 | 91 | 105 | |
| Total Assets | 47 | 59 | 77 | 116 | 111 | 117 | 126 | 130 | 137 | 144 | 90 | 104 | 119 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7 | 7 | 5 | 25 | 5 | 20 | 10 | 5 | 9 | 5 | 6 | 13 | |
| -9 | 7 | 4 | -30 | 32 | -0 | 2 | 1 | 3 | 4 | 3 | 1 | |
| 0 | 0 | 0 | 0 | -10 | 10 | 0 | -2 | -1 | -3 | -71 | 0 | |
| Net Cash Flow | -1 | 14 | 8 | -5 | 26 | 31 | 12 | 3 | 10 | 6 | -62 | 14 |
| Free Cash Flow | 6 | 4 | 3 | 23 | 4 | 19 | 9 | 3 | 8 | 3 | 4 | 11 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 105% | 89% | 57% | 128% | 59% | 347% | 166% | 101% | 128% | 106% | 71% | 138% |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 67 | 81 | 80 | 61 | 71 | 77 | 64 | 58 | 51 | 52 | 74 |
| Inventory Days | 84 | 106 | 128 | 132 | 83 | 106 | 123 | 103 | 61 | 95 | 125 | 101 |
| Days Payable | 36 | 52 | 66 | 157 | 43 | 72 | 101 | 79 | 55 | 54 | 40 | 69 |
| Cash Conversion Cycle | 108 | 120 | 144 | 56 | 101 | 106 | 98 | 88 | 64 | 91 | 138 | 106 |
| Working Capital Days | 105 | 103 | 121 | 72 | 131 | 98 | 90 | 78 | 62 | 77 | 91 | 76 |
| ROCE % | 29% | 33% | 35% | 40% | 24% | 10% | 9% | 8% | 11% | 12% | 19% | 17% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Manufactured products as % of total revenue % |
|
||||||||||
| Permanent employees on rolls count |
|||||||||||
| Export revenue as % of total revenue % |
|||||||||||
| Top 3 customer concentration as % of revenue % |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- We hereby submit newspaper publication of the Un-Audited Financial Results for the quarter and half year ended September 30, 2026.
- Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2026
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, November 04, 2026 To Consider And Approve The Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2026.
- Board approved Q2/H1 FY2026-27 unaudited results; PAT rose to Rs 706.22 lakh.
-
Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2026.
- Board meets November 4, 2026 to approve Q2 and half-year unaudited results; trading window closed until November 6.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Company submitted Regulation 74(5) compliance certificate for quarter ended September 30, 2026.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1][2]
MBIL is a part of Multibase SA, a subsidiary of DuPont de Nemours, Inc. It is an integrated manufacturer of thermoplastic elastomers and silicone-based products, serving industries such as automotive, building, and construction. It offers customised thermoplastic solutions and exports products to global markets.